People | January 04, 2026
AstraZeneca elevates Vikram Chand as SVP, Head of R&D for Japan
Dr. Chand held several leadership positions within AstraZeneca and the broader biopharmaceutical industry
Dr. Chand held several leadership positions within AstraZeneca and the broader biopharmaceutical industry
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
Once finalized, cough syrups will no longer be available for over-the-counter sale
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer
The trials did not show a statistically significant reduction in annualized clinical fracture rates compared to placebo or bisphosphonates
The company announced that it has been granted patent covering “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives.”
The study will run across 18 sites and enroll roughly 200 patients over 24 months
The accelerated review covers WCK 5222 for multiple critical infections
Subscribe To Our Newsletter & Stay Updated
